From Prostate Cancer Foundation:
Your PSA is going up. What’s going on with your prostate? Good news: “second-line” blood and urine tests can provide answers and help guide treatment.
Read more about it HERE
Blood and Urine Tests for Prostate Cancer
PCRI 2020 Mid Year Conference Update – Now Free Online Livestream
The PCRI 2020 mid year conference on March 28th 10:30AM has been changed from an onsite event to a FREE online live streaming event due to the recent corona virus situation.
Please check the pcri.org website for further details that will be made available in the coming days. You now have an opportunity to participate in this mid year conference from the comfort and safety of your home.
Further updates on refunds to those that have already registered will be made available by PCRI soon. If you have made travel arrangements and bookings (airline/hotel), please remember to make the necessary cancellations.
Download Updated 2019 Prostate Cancer Patient Guide
Prostate Cancer Foundation’s goal is always to deliver the most cutting-edge treatments and information to families dealing with prostate cancer. As such, they have committed to updating the patient guide to reflect the very latest research and discoveries for patients.
This is our third round of updates for 2019. Changes include:
- Updated information on local treatments for recurrent prostate cancer
- Updated information on therapies for metastatic hormone-sensitive prostate cancer
- New FDA approval of darolutamide for non-metastatic CRPC
- New information about non-hormonal therapy options for select patients
- New information on the use of PARP inhibitors as an emerging therapy
- Updated recommendations on when to talk to your doctor about PSA screening
- Updated nutrition recommendations
Download an updated digital copy today and then be sure to provide feedback.
Advanced Prostate Cancer Consensus Conference 2019 Videos
URO Today has published a collection of videos from the APCC 2019 conference. This informative collection of 60 short videos cover a wide range of prostate cancer topics. You can view the video collection on URO Today HERE
Prostate Cancer Glossary and Drugs List
Don’t get confused with all the various prostate cancer terms and drugs. The following resources can help you with these. You can also find these links in the Resources section of this website.
Updated 2019 Prostate Cancer Patient Guide
PCF has updated it’s 2019 Patient Guide. Compiled with the contributions of top-tier doctors and researchers in prostate cancer, it is a must-have resource for patients and families. It focuses all of the information available about contemporary prostate cancer research, treatment, and lifestyle factors into one consolidated document.
Get it HERE.
More Than One Prostate Cancer in a Single Prostate?
As many as 40% of newly diagnosed PCa patients have unifocal disease, that is, just one focus of cancer. But that still leaves 60-80% of patients with multifocal PCa. Without evidence to the contrary, multiple foci in the same gland were thought to be biologically homogeneous, that is, identical to each other.
Then, along came the tools to analyze PCa at the molecular level, bringing new knowledge of the biology of PCa.
Read about this by clicking here.
How to train your bladder
If you experience a frequent urge to urinate—perhaps due to having an enlarged prostate if you’re a man, having given birth if you’re a woman, or having an “overactive bladder”—there may be a practical do-it-yourself solution to the problem, referred to as bladder training. It’s worth a try before resorting to medication or surgical procedures.
Read more at berkeleywellness.com HERE
What are Some Other Causes for a High PSA?
So you’ve had your PSA test, and it came back high. Your doctor did a DRE and ran a few more tests, and assures you that prostate cancer is very unlikely. Still, you’re worried. What are some other causes of a high PSA?
Read about this in the Prostate Care Foundation blog HERE
Research finds ‘Achilles heel’ for aggressive prostate cancer. Drug makes prostate cancer cells self destruct
UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology. Experiments in mice and with human cells showed that blocking this stress response with an experimental drug—previously shown to enhance cognition and restore memory after brain damage in rodents—causes treatment-resistant cancer cells to self-destruct while leaving normal cells unaffected.
The new study was published online May 2, 2018 in Science Translational Medicine.
Read the entire article on MedicalXpress.com HERE
and technologyneworks.com HERE